Researching Complex Interventions in Health: The State of the Art : Exeter, UK. 14-15 October 2015. by Craig, P et al.
BMC Health Services Research 2016, Volume 16 Suppl 1
DOI 10.1186/s12913-016-1274-0ABSTRACTS Open AccessResearching Complex Interventions in
Health: The State of the Art
Exeter, UK. 14-15 October 2015
Published: 4 April 2016KEYNOTE PRESENTATIONS
K1
Researching complex interventions: the need for robust
approaches
Peter Craig (peter.craig@glasgow.ac.uk)
MRC/CSO Social and Public Health Sciences Unit (SPHSU), University of
Glasgow, 200 Renfield Street, Glasgow G2 3QB, UK
BMC Health Services Research 2016, 16(Suppl 1):K1
Since the revised MRC guidance on the development and evaluation
of complex interventions was published in 2008, much progress has
been made in developing and defining good practice, and there is
an increasingly detailed and comprehensive set of guidance available
to help researchers and funders make the right choices. But progress
is patchy, and evidence continues to accumulate of waste in re-
search. Robust approaches are needed, that combine good practice
across all stages of the evaluation process, from the initial choice and
framing of research questions, through to implementation and trans-
lation of evidence. The elements of a robust approach are mostly
well-known, but much more rarely are they combined into a coher-
ent package. The talk will consider why this is so, and what can be
done to improve matters.
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Complex intervention studies: an important step in developing
knowledge for practice
Ingalill Rahm-Hallberg (ingalill.rahm_hallberg@rektor.lu.se)
Lund University, PO Box 117, 221 00 Lund, Sweden
BMC Health Services Research 2016, 16(Suppl 1):K2
This presentation will provide the history of the “Complex Inter-
ventions in Health” book. The development of the book took off
in the European Academy of Nursing Science (EANS) summer
school. For more than 12 years the EANS has gathered doctoral
students from all over Europe in a three year programme. The
content developed over time, inspired by the critique stating that
nursing research was heavily dominated by descriptive, cross-
sectional or qualitative research not really informing practice. This
lead to building a curriculum based on the MRC guidance on com-
plex interventions and the teaching programme became truly suc-
cessful among students. The road to developing the content for a
book was short. Professor Richards and I played around on the
black board and after that it has been a success-story. So many
authors delivering on time! However, rightfully we have been told
that research in health is more than researching complex inter-
ventions. I cannot agree more, it is only one step, but a very im-
portant one. Health research, as any research with aspirations for
informing practice, needs to be carried out systematically and pro-
grammatically, using a variety of designs and methods. It is helpful
to think of knowledge development as being a stepwise process
starting off with discovery and once possible going into the phase© 2016 The Author(s). Open Access This artic
International License (http://creativecommons
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(http://creativecommons.org/publicdomain/zeof evaluation and once solid knowledge is obtained it is about im-
plementation in practice.
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Public and patient involvement in research: what, why and how?
Nicky Britten (N.Britten@exeter.ac.uk)
University of Exeter Medical School, South Cloisters, St Luke’s Campus,
Exeter EX1 2LU, UK
BMC Health Services Research 2016, 16(Suppl 1):K3
In this presentation I will explain what PPI is, what it isn’t, and how it
differs from engagement, as there is some misunderstanding. There
is a range of both ethical and pragmatic reasons for involving mem-
bers of the public and patients in research, depending on the differ-
ent values and perspectives of those involved. I will provide practical
examples of PPI at different stages of the research cycle: identifying
and prioritising research questions; developing research proposals;
doing research; analysing research data; disseminating and imple-
menting findings; as well as PPI in systematic reviewing and oper-
ational research. Drawing on my own research, I will use the
particular example of the Diabetes Intervention for Agenda Trial
(DIAT) to illustrate PPI in a trial from start to finish. I will present a
theoretical framework for characterising PPI which paradoxically is of
practical value in reflecting on PPI practice. Finally I will present the
Public Involvement Impact Assessment Framework (the PiiAF) for
helping to evaluate the various intended and unintended impacts of
PPI.
K4
Mixed methods in health service research – where do we go from
here?
Gunilla Borglin (gunilla.borglin@mah.se)
Department of Caring Science, Malmö University, SE-205 06 Malmö,
Sweden
BMC Health Services Research 2016, 16(Suppl 1):K4
In the 21st century, it is more obvious than ever before that health
services research and its practitioners exist in an extremely complex
contextual environment. Consequently, at the heart of understanding
how to deliver an evidence base for safe and effective care in a set-
ting characterised by multifaceted health care demands, is the real-
isation that no one research method in isolation will suffice. This
realisation, together with the REWARD group’s contention that 85 %
of health service research conducted – and most importantly mainly
funded by public money – is ‘waste’, is one of the reasons why
frameworks such as the MRC guidance on complex interventions,
and mixed methods designs are subject to intensified attention. This
plenary address aims to discuss the contribution of mixed methods
to researching complex interventions within the MRC framework and
to consider its place in contemporary health service research. The MRC
framework for researching complex interventions has highlighted thele is distributed under the terms of the Creative Commons Attribution 4.0
.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
ive appropriate credit to the original author(s) and the source, provide a link to
changes were made. The Creative Commons Public Domain Dedication waiver
ro/1.0/) applies to the data made available in this article, unless otherwise stated.
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tive approaches. However when reviewing the literature prior to writing
my chapter in our recent textbook, it was clear that designing and
conducting truly mixed methods research presents health service re-
searchers with a number of challenges. Predominant amongst these
are the selection of designs from suggested typologies, methodological
reporting, critical evaluation and most importantly ensuring that the
core feature in true mixed methods (as opposed to multi-methods) de-
signs – analytical and methodological integration – is implemented. To
be able to conduct mixed methods approaches that are rigorously de-
signed, logically executed, and transparently reported, we need to
move to a position where funders, researchers, journal editors and re-
search consumers demand methodological integration of methods and
data from study outset, rather than as a mere afterthought in the dis-
cussion section of research reports.
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Exploring complexity in systematic reviews of complex
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There is a lot of discussion about the most adequate approaches to
perform systematic reviews and meta-analyses of complex interven-
tions. Reviewers need to broaden their view and to have a detailed
look at all available evidence for the whole process of developing
and evaluating complex interventions. Decisions about approaches
should acknowledge intervention aims. Decisions about the scope
and methods of the systematic review depend on the available infor-
mation, which should be assessed in view of clinicians’ and patients’
needs. Important decisions include the type of evidence to be searched
and the choice of methods to describe or synthesise it. This will usually
require a combination of different study types including quantitative
and qualitative data. Transparent reporting is a key issue to allow
readers to apply the findings to specific contexts.
S2
Can complex health interventions be optimised before moving to
a definitive RCT? Strategies and methods currently in use
Sara Levati (Sara.Levati@gcu.ac.uk)
NMAHP Research Unit, Glasgow Caledonian University, UK
BMC Health Services Research 2016, 16(Suppl 1):S2
RCTs are recognised as the ‘gold standard’ methodology in the evalu-
ation of complex interventions, however, they often fail to detect
whether the lack of intervention effect is due to sub optimal design,
implementation failure or genuine ineffectiveness. Given the current
financial constraints upon health services research, it is increasingly
important to define pre-trial optimisation methods that can give indi-
cations on how the intervention works and help maximise chances
for the intervention to be effective. This scoping review provides a
map of the health literature on pre-trial strategies aimed at opti-
mising complex interventions before a RCT and a snapshot of the
methods currently used. Scholarly literature was searched using
MEDLINE, CINAHL, AMED, PsycINFO and ProQuest Nursing & Allied
Health Source for papers published between January 2000 and
March 2015 available in English language. The literature search
identified 3940 unique references, 27 of which met the inclusion cri-
teria. Optimisation strategies explored the feasibility and acceptabil-
ity of the intervention to patients and healthcare professionals,
estimated the effectiveness and cost-effectiveness of different com-
binations of components and identified potential barriers to implemen-
tation. Large variations in the methods adopted were noted acrossstudies, including interviews and focus groups with interventions’
providers and receivers, experts consultations, economic modelling,
small uncontrolled pilot studies and evaluation questionnaires. Overall,
there is the potential for optimisation strategies to detect, in a cost-
effective way, those interventions and components that are likely to fail
or show little effect if implemented in a full-scale RCT.
S3
A systematic approach to develop theory based implementation
interventions
Anne Sales (salesann@med.umich.edu)
School of Nursing, University of Michigan, USA and Center for Clinical
Management Research, VA Ann Arbor Healthcare System, USA
BMC Health Services Research 2016, 16(Suppl 1):S3
In this presentation, I will briefly review the large landscape of frame-
works and theories in implementation research, and suggest an ap-
proach to designing implementation interventions that builds on
current widely cited frameworks to develop theory-based implemen-
tation interventions.
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Pilot studies and feasibility studies for complex interventions: an
introduction
Lehana Thabane1, Lora Giangregorio2
1McMaster University, Canada; 2University of Waterloo, Canada
Correspondence: Lehana Thabane (thabanl@mcmaster.ca) – McMaster
University, Canada
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Pilot studies for phase III trials—which are comparative randomized
trials designed to provide preliminary evidence on the clinical effi-
cacy of an intervention—are routinely performed in many clinical
areas. Also commonly known as “feasibility”, “dress rehearsal” or
“vanguard” studies, they are designed to assess recruitment poten-
tial; to assess the feasibility of international collaboration or coordin-
ation for multicentre trials; to increase clinical experience with the
study intervention for the phase III trials. They are the best way to as-
sess feasibility of a large, expensive full-scale study, and in fact are
an almost essential pre-requisite (Thabane et al (BMC Medical Re-
search Methodology 2010, 10:1). Conducting a pilot prior to the main
study can enhance the likelihood of success of the main study and
potentially help to avoid doomed main studies. The presentation will
cover some key aspects of pilot studies for phase III trials of complex
interventions including: 1) reasons for conducting a pilot study; 2)
misconceptions about pilot studies; 3) criteria for evaluating the suc-
cess of a pilot study; 4) differences and similarities between pilot and
feasibility studies; and 5) a brief update on the development of CON-
SORT extension for pilot trials.
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What can be done to pilot complex interventions?
Nancy Feeley1, Sylvie Cossette2
1Ingram School of Nursing, McGill University, and Centre for Nursing
Research and Lady Davis Institute, Jewish General Hospital, Montreal,
Québec, Canada; 2Faculty of Nursing, University of Montreal, and
Montreal Heart Institute Research Center, Montreal, Québec, Canada
Correspondence: Nancy Feeley (nancy.feeley@mcgill.ca) – Ingram
School of Nursing, McGill University, and Centre for Nursing Research and
Lady Davis Institute, Jewish General Hospital, Montreal, Québec, Canada
BMC Health Services Research 2016, 16(Suppl 1):S5
In a pilot or feasibility study, the feasibility and acceptability of many
of the key features of a complex intervention can be examined. The
main research questions are: Can the intervention be provided as
planned? Is the intervention acceptable to participants? Certain features
(e.g., content, sequence, dose, timing, mode of delivery) will be more
important to scrutinize than others, depending on the particular
BMC Health Services Research 2016, Volume 16 Suppl 1 Page 3 of 5challenges anticipated and the questions that remain at the end
of intervention development. This presentation will examine which
intervention features might be examined in a pilot study, and describe
examples of studies that have done so. In addition, special issues such
as contamination and co-intervention will be discussed.
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Using feasibility and pilot trials to test alternative methodologies
and methodological procedures prior to full scale trials
Rod Taylor (R.Taylor@exeter.ac.uk)
University of Exeter Medical School, South Cloisters, St Luke’s Campus,
UK
BMC Health Services Research 2016, 16(Suppl 1):S6
Feasibility and pilot studies play a key role in health research, in pro-
viding information for the planning of full scale randomised controlled
trials. Medical Research Council guidance for development and evalu-
ation of complex interventions states that pilot and feasibility studies
are essential in the development and testing of an intervention prior to
a large-scale evaluation. Before committing investment in costly and
time-consuming full scale trials, funding bodies increasingly demand
that investigators provide evidence from pilot/feasibility studies ad-
dressing the question: “Can this full scale trial be done?” This presenta-
tion will: (i) identify the common methodological uncertainties in the
design and execution of full scale trials; (ii) review approaches to testing
these methodological uncertainties in feasibility/pilot studies; and (iii)
discuss the design and selection of feasibility and pilot studies to best
address these uncertainties. These concepts will be illustrated by refer-
ence to recent feasibility/pilot studies.
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A mixed methods feasibility study in practice
Jacqueline Hill1, David A Richards2, Willem Kuyken3
1Mood Disorders Centre, School of Psychology, University of Exeter, UK;
2University of Exeter Medical School, UK; 3Department of Psychiatry,
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Correspondence: Jacqueline Hill (j.j.hill@exeter.ac.uk) – Mood Disorders
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Depression is set to become the third biggest cause of the global
burden of disease by 2030 yet access to treatment is poor. To maxi-
mise access, worldwide psychological therapies for depression are
delivered using a system called stepped care. However, we do not
know if this system achieves similar patient benefit for less cost com-
pared with alternatives. A fully-powered clinical trial of stepped care
is required but currently prevented by a number of uncertainties.
This presentation will describe how we chose to answer these in a
single feasibility study encompassing a pilot randomised controlled
trial and embedded qualitative interviews. In particular, the presenta-
tion will focus on the innovative use of integrated mixed methods
analysis to explore how patients’ views of stepped care and the num-
ber of treatment sessions they attend relate. In this way, we will illus-
trate how it is possible to interweave quantitative and qualitative
data in original ways as part of a feasibility study to address multiple
clinical, procedural and methodological uncertainties.
S8
Non-standard experimental designs and preference designs
Louise von Essen (louise-von.essen@pubcare.uu.se)
Department of Public Health and Caring Sciences, Uppsala University,
Sweden
BMC Health Services Research 2016, 16(Suppl 1):S8
Randomized controlled trials (RCT) have been accepted as the
‘gold standard’ design for evaluating the effectiveness of a singleintervention such as a drug. However, recruitment to clinical trials
may be affected by the choice of intervention that participants
might make, if they were allowed to choose, and by whether they
actually receive their preferred intervention. These effects cannot
be estimated in the RCT design. Additionally the RCT runs counter
to the current emphasis on patient choice which is the corner-
stone in many governments’ current health strategies and where
preferences or ethical objections to an RCT exist, alternatives that
replicate more closely the behaviors in real world health care ra-
ther than conform to standard trial design should be considered.
Citizen participation in research is advocated by governments, re-
search councils, and other funding bodies and as the public, pa-
tients, and significant others become more involved in research
activities they may be unwilling to be passive participants of a
research randomization process. Non-standard and preference de-
signs go some way towards addressing the problems of low re-
cruitment and retention rates and non-implementation of results
of clinical research. Advantages and challenges e.g. with regard to
internal and external validity with non-standard and preference
designs such as the comprehensive cohort design, pre-randomized
design, cohort multiple randomized controlled trial, and two-stage
randomized design will be presented at the conference.
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Evaluation gone wild: using natural experimental approaches to
evaluate complex interventions
Andrew Williams (A.J.Williams@ed.ac.uk or a.williams2@exeter.ac.uk)
Farr Institute, Scotland, and the Scottish Collaboration for Public Health
Research and Policy, 20 West Richmond Street (East Wing), Edinburgh
EH8 9DX, UK
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Any outcome evaluation of an intervention needs to address the fol-
lowing questions:
1. Did change occur?
2. Was the change due to the intervention?
3. Was the change significant/meaningful? (Sanson-Fisher et al, 2014) [1]
With the ability to calculate the unbiased attributable effects on an
intervention the randomised controlled trial (RCT) is seen as the ‘gold
standard’ method for answering all three questions. However, as
complex interventions are recognised as events within systems, they
are rarely tame enough for RCTs to be feasible (Hawe et al., 2009)
[2]. The natural experimental approaches (NEAs) permit quasi-
experimental evaluation which can answer the three questions when
the intervention is wilder, particularly when routinely collected out-
come data are available (Craig et al., 2011) [3].
Robust NEAs rely on quasi-randomised identification (instrumental
variable, regression discontinuity or propensity score matching) of a
control (counterfactual) population to compare with the intervention
population. Subsequently, taking a difference in differences or con-
trolled before-after approach permits the calculation of an effect at-
tributable to the intervention addressing the three questions. Quasi-
randomised scenarios often occur by chance (naturally, not designed
as part of an evaluation) within complex interventions allowing valu-
able prospective or retrospective evaluation. For example, criterion-
based intervention eligibility permitting a regression discontinuity
design. Although not faultless, NEAs offer an often missed opportun-
ity to evaluate complex interventions.
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The stepped wedge cluster randomised trial (SW-CRT) is a novel
research study design that is increasingly being used in the
evaluation of service delivery type interventions. The design in-
volves random and sequential crossover of clusters from control
to intervention, until all clusters are exposed. We illustrate the
use of the design by giving case examples, summarise the results
of an update of a methodological systematic review of the qual-
ity of reporting and provide recommendations for reporting and
analysis. The use of the SW-CRT is rapidly increasing and areas of
use are diverse. We illustrate how the design is being used to
evaluate the effectiveness of a complex intervention, being
rolled-out across 90 UK hospitals, to reduce mortality in patients
undergoing emergency laparotomy. Quality of reporting is found
to be low. In a SW-CRT more clusters are exposed to the inter-
vention towards the end of the study than in its early stages. A
result which prima facia might look to be suggestive of an effect
of the intervention may therefore transpire to be the result of a
positive underlying temporal trend. A large number of studies do
not report how they allowed for temporal trends in the design or
analysis. The SW-CRT is a pragmatic study design which can rec-
oncile the need for robust evaluations with political or logistical
constraints. Quality and reporting is generally low and so consen-
sus guidelines on reporting and analysis are urgently needed.
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Adaptive designs in confirmatory clinical trials: opportunities in
investigating complex interventions
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Adaptive designs are now considered innovative alternative trial
designs with potential to improve efficiency in clinical trials re-
search when appropriately used to answer research questions.
Their appropriate implementation in confirmatory trials is gain-
ing widespread attention among researchers, public funders and
regulators. Based upon findings from our review of confirmatory
adaptive designs, this talk focuses on acceptable scope with
huge potential to be implemented in confirmatory trials setting.
In theory, although adaptive designs could be applied across a
wide range of study interventions, attention will be given to
complex interventions, with relevant examples without focusing
much on technical statistical details. This study is funded by
the NIHR investigating the use of adaptive designs in publicly
funded confirmatory trials with an aim to come up with a
guidance document and recommendations for their appropriate
use.S12
Processes, contexts and outcomes in complex interventions, and
the implications for evaluation
Mark Petticrew (Mark.Petticrew@lshtm.ac.uk)
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BMC Health Services Research 2016, 16(Suppl 1):S12
It would be convenient if there were two categories of interventions -
simple and complex – but of course this is not the case. Instead
interventions can be placed on a spectrum of complexity. For sim-
pler interventions there is often a relatively well-understood (or
perhaps just well-accepted) causal pathway between the inter-
vention and its outcomes. This may derive from basic science - for
example if the physiological pathways between particular medical
interventions and changes in outcomes have been previously
shown. For more complex interventions - those in which the inter-
vention interacts with and adapts within its social context - such
pathways may be less well understood, less predictable (or even
chaotic) and, crucially, non-linear. Here, the intervention may not
even be easily distinguishable from the context. In such situations
it may be more productive to move away from identifying “in-
terventions” and “components,” towards seeing interventions as
changes systems (Hawe et, al. 2009) [1] rather than as discrete
events, or as “packages” of interconnected elements. Such a per-
spective has major implications for how we conceptualise and
evaluate public health interventions. This presentation will discuss
the implications for evaluation, using recent examples from public
health.
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Attempts to address health problems increasingly involve the devel-
opment and evaluation of ‘complex interventions’. In addition to out-
comes evaluation, understanding complex intervention mechanisms,
how interventions are implemented, and how they produce change
in specific contexts, is essential if findings are to inform policy and
practice. For this, process evaluation is vital. MRC guidance for evalu-
ating complex interventions, published in 2008, recognised the value
of process evaluation alongside trials of effectiveness, though pro-
vided little insight into how to conduct process evaluation. In 2010, a
workshop funded by the MRC Population Health Science Research
Network (PHSRN) identified a need for guidance to fill this gap. Fol-
lowing the workshop, 11 researchers with experience of public health
evaluations developed draft guidance, drawing upon reviews of the
literature, group discussions of case studies and feedback obtained
at a number of conference workshops. Academic, policy and practice
stakeholders were also consulted during the development of the
guidance. The new guidance sets out a framework for linking core
functions of process evaluation, understanding implementation,
mechanisms of impact and context. It provides assistance in plan-
ning, designing, conducting, reporting and appraising process evalu-
ations, and argues for a systematic approach to designing and
conducting process evaluations, drawing on clear descriptions of
intervention theory and identification of key empirical uncertainties.
While acknowledging that each process evaluation will be different,
BMC Health Services Research 2016, Volume 16 Suppl 1 Page 5 of 5the guidance assists in thinking through common decisions to be
made when planning and conducting a process evaluation, and pro-
vides a framework for peer review.
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Qualitative evaluations are becoming increasingly commonplace
alongside RCTs. They provide useful insight into the way things work
within RCTs, particularly insight into the how and why things work,
and contextualise RCT effects. While there are established guidelines
for conducting qualitative research, there is less guidance on how to
go about qualitative process evaluations alongside RCTs. Our presen-
tation will discuss how to enhance the utility of qualitative evalua-
tions in explaining RCT effects, through identifying key issues, such
as involvement of trialists in the evaluation; scaling the evaluation;
and maintaining the integrity of the trial. We discuss these issues by
reflecting on practical examples of qualitative evaluations conducted
in South Africa.
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The economic evaluation of complex interventions may be problem-
atic for many reasons generally underpinned by ‘complexity’ of the
intervention but more specifically because of the potential number
of relevant patient outcomes. This presentation will begin by pre-
senting an overview of methods of economic evaluation used by
decision-making bodies such as the National Institute for Health and
Care Excellence and then describe a programme of work that fo-
cused on clinical genetics services, as an example of a complex inter-
vention, to illustrate why sometimes maximising health status alone
is not sufficient. Genetic services and tests, are a good example of a
complex intervention and have broader objectives than just health
gain, which may usefully be measured using the concept of capabil-
ity to make an informed decision. The presentation will conclude by
describing the further methodological work required to ensure the
methods to value outcomes continue to consider opportunity cost
and are therefore, suitable for informing resource allocation decisions
with the constraints of a finite healthcare budget.S16
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Theo van Achterberg (theo.vanachterberg@med.kuleuven.be)
Leuven University KU Leuven, Belgium
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The presentation “How to arrive at an implementation plan” will
highlight the most important steps to be taken in the development
of an implementation plan, using examples from research and prac-
tice. These include 1) analysing barriers and facilitators for imple-
mentation and linking these to relevant concepts, 2) using these
concepts to find and consider theories that can inform the selection
of implementation strategies, 3) considering effectiveness of com-
mon strategies, and 4) collaborating with target groups and stake-
holders in operationalising strategies into a practical implementation
plan. Well considered preparations such as these are crucial to im-
plementation success, and thus optimising chances of effective im-
provement in healthcare.
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In this presentation, I focus on probably the least studied and under-
stood element of developing a complex intervention: modelling the
complex intervention by putting together all ‘active components’
that are known to have an effect based on empirical evidence or the-
ory. I will discuss several problems: What active ingredients to select?
How do we know that the intervention is the best one? How to opti-
mise? How to anticipate on barriers in implementation? These prob-
lems will be discussed making use of a practical example.
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The growing complexity of health care coupled with the ever-
increasing pressures to ensure efficient and effective use of limited
resources have encouraged policy makers to turn to system model-
ling solutions. Such techniques have been available for decades, but
despite ample research which demonstrates potential, their applica-
tion in health services to date is limited. This presentation surveys
the breadth of approaches available to support delivery and design
across many areas and levels of healthcare planning. Case studies will
be presented to exemplify how impactful application of health system
modelling can be achieved and demonstrate how policy making can
benefit from the application of these tools. This is followed by a discus-
sion of the key issues surrounding the use of these methods in health,
what barriers need to be overcome to ensure more effective imple-
mentation, and the likely developments in the future.
